Mollie Leoni sold $834K of Kura Oncology (KURA)

Executed Jun 18, disclosed Jun 22, 4 days later.

Value, as filed

$834K

84,929 sh × $9.82

Executed

Jun 18

the trade date, as filed

Disclosed

Jun 22

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

ML Mollie Leoni Chief Medical Officer profile →

Mollie Leoni (Chief Medical Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Kura Oncology, Inc. (KURA). The largest single filing was $834K of KURA (84,929 sh × $9.82, as filed), executed Jun 18.

The name

KURA Kura Oncology, Inc. KURA · Healthcare · 15 filings in 24 months ticker →

Healthcare · Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Mollie Leoni in KURA

KURASALE Kura Oncology, Inc. $440K
41,250 sh across 2 lots
Exec Sep 28
Filed Sep 29 · 6:30 PM ET KURASALE Kura Oncology, Inc. $173K
15,485 sh × $11.18
Exec Nov 14 2025
Filed Nov 14 2025 · 5:30 PM ET KURASALE Kura Oncology, Inc. $110K
12,314 sh × $8.94
Exec Sep 29 2025
Filed Sep 29 2025 · 5:30 PM ET